![David Loomis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 369 776 $ al 31/08/2026
Mr. David Loomis is a Chief Accounting Officer & Vice President at Arvinas, Inc. Mr. Loomis was previously employed as a Controller by Biohaven Ltd. and a Controller by Biohaven Pharmaceutical Holding Co. Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARVINAS, INC. 0,06 % | 11/05/2026 | 40.193 ( 0,06 % ) | 369 776 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARVINAS, INC. | Comptroller/Controller/Auditor | 07/11/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Comptroller/Controller/Auditor | 01/11/2022 |
| BIOHAVEN LTD. | Comptroller/Controller/Auditor | 01/11/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Biohaven Ltd.
 Biohaven Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
